These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6688037)

  • 1. Ventricular fibrillation following AMSA. Uncomplicated retreatment following correction of hypokalemia.
    McLaughlin P; Salvador PG; Cabanillas F; Legha SS
    Cancer; 1983 Aug; 52(3):557-8. PubMed ID: 6688037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular fibrillation, hypokalemia, and AMSA therapy.
    Foldes JA; Yagil Y; Kornberg A
    Ann Intern Med; 1982 Jan; 96(1):121-2. PubMed ID: 6947708
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
    Von Hoff DD; Elson D; Polk G; Coltman C
    Cancer Treat Rep; 1980; 64(2-3):356-8. PubMed ID: 6931630
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).
    Falkson G
    Cancer Treat Rep; 1980; 64(2-3):358. PubMed ID: 6157470
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic reaction following administration of AMSA.
    Rosenfelt FP; Rosenbloom BE; Weinstein IM
    Cancer Treat Rep; 1982 Mar; 66(3):594-5. PubMed ID: 6460556
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac abnormalities after AMSA administration.
    Steinherz LJ; Steinherz PG; Mangiacasale D; Tan C; Miller DR
    Cancer Treat Rep; 1982 Mar; 66(3):483-8. PubMed ID: 6949643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMSA-induced seizures in patients with hypokalemia.
    Mittelman A; Arlin ZA
    Cancer Treat Rep; 1983 Jan; 67(1):102-3. PubMed ID: 6688555
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
    Kearsley JH; Page JP; Levi JA; Woods RL; Tattersall MH; Fox RM; Coates AS
    Aust N Z J Obstet Gynaecol; 1982 May; 22(2):107-9. PubMed ID: 6958247
    [No Abstract]   [Full Text] [Related]  

  • 10. AMSA therapy for children with lymphoblastic malignancy.
    Hutter JJ; Meyskens FL
    Cancer Treat Rep; 1982 Mar; 66(3):593-4. PubMed ID: 6949644
    [No Abstract]   [Full Text] [Related]  

  • 11. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hepatotoxicity associated with AMSA therapy.
    Appelbaum FR; Shulman HM
    Cancer Treat Rep; 1982 Oct; 66(10):1863-65. PubMed ID: 6957265
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Ryan DH
    Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMSA toxicity in patients with abnormal liver function.
    Mahal PS; Legha SS; Valdivieso M; Luna M; Benjamin RS; Bodey GP
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1343-8. PubMed ID: 6896030
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac arrhythmia associated with AMSA in a child: a Southwest Oncology Group Study.
    Riela AR; Kimball JC; Patterson RB
    Cancer Treat Rep; 1981; 65(11-12):1121-3. PubMed ID: 6945913
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
    Weil M; Auclerc MF; Schaison G; Auclerc G; Daubrisson A; Degos L; Caro J; Marty M; Jacquillat GI
    Nouv Presse Med; 1982 Oct; 11(39):2911-4. PubMed ID: 6755389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
    Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
    Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 20. Amsacrine (AMSA)--a clinical review.
    Louie AC; Issell BF
    J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.